DIABETESMAG.NET


FDA APPROVES FIRST AUTOMATED INSULIN DELIVERY DEVICE FOR TYPE 1 DIABETES




The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes. The human pancreas naturally supplies a low, continuous rate of insulin, known as basal or background insulin. In patients with diabetes, the body’s ability to produce or respond to insulin is impaired.


Click Here For A Random Health Stories